Takeda Pharmaceuticals, the maker of the world's best-selling diabetes drug Actos, has had hundreds of lawsuits filed against them. Click here to read more about the lawsuit. More evidence shows that taking the pill for more than a year raises individuals' risks for developing bladder cancer. Click here to read about other risks associated with Actos. In June, the company stopped sales of Actos in Germany and France because of increased pressure from regulators. In the U.S., sales have continued, but the FDA has issued warnings … [Read more...]
Actos banned in France after Drug Linked to Bladder Cancer
June 27, 2011 By
Are Americans in Danger? Actos has been pulled from the shelves in France and Germany after the popular diabetes drug was linked to bladder cancer. The prescription drug is typically used in the U.S. along with diet and exercise to lower blood sugar levels in treating type 2 diabetics. It was suspended because of concerns saying it gave patients an increased risk of developing bladder cancer. CBS News reported the French Medicines Agency pulled Actos in addition to the pill Competact - a drug that combines Actos and the popular diabetes drug … [Read more...]
